{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tiotropium+Bromide", "query": { "intervention": "Tiotropium Bromide" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 135, "total_pages": 14, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tiotropium+Bromide&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T08:02:01.838Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01290874", "title": "Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Tiotropium", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Formoterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1070, "start_date": "2011-03-30", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2018-03-30", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 13, "location_summary": "Jacksonville, Florida • Marietta, Georgia • Newton, Georgia + 10 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Newton", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01290874" }, { "nct_id": "NCT00578968", "title": "Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "COPD" ], "interventions": [ { "name": "Tiotropium", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "35 Years to 85 Years" }, "enrollment_count": 36, "start_date": "2006-10", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2012-06-26", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00578968" }, { "nct_id": "NCT00523991", "title": "Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 457, "start_date": "2007-04", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-20", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Palo Alto, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00523991" }, { "nct_id": "NCT01483625", "title": "Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 140, "start_date": "2011-11", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 27, "location_summary": "Tucson, Arizona • Riverside, California • San Diego, California + 24 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01483625" }, { "nct_id": "NCT01533922", "title": "Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" }, { "name": "Olodaterol", "type": "DRUG" }, { "name": "Tiotropium + Olodaterol", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 295, "start_date": "2012-03", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-09-15", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 8, "location_summary": "Torrance, California • Hartford, Connecticut • Livonia, Michigan + 5 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Livonia", "state": "Michigan" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Easley", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01533922" }, { "nct_id": "NCT03478683", "title": "A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" }, { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "Placebo to match budesonide/formoterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "Placebo to match FF/UMEC/VI", "type": "DRUG" }, { "name": "placebo to match tiotropium", "type": "DRUG" }, { "name": "ELLIPTA", "type": "DEVICE" }, { "name": "MDI", "type": "DEVICE" }, { "name": "HandiHaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 729, "start_date": "2018-06-25", "completion_date": "2019-03-14", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 40, "location_summary": "Gold River, California • Clearwater, Florida • DeBary, Florida + 31 more", "locations": [ { "city": "Gold River", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeBary", "state": "Florida" }, { "city": "Edgewater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03478683" }, { "nct_id": "NCT00463567", "title": "26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive", "COPD", "Lung Diseases, Obstructive" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Formoterol (12 µg b.i.d.)", "type": "DRUG" }, { "name": "Tiotropium (18 µg o.d.)", "type": "DRUG" }, { "name": "Placebo to Indacaterol", "type": "DRUG" }, { "name": "Placebo to Formoterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2059, "start_date": "2007-04", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2011-08-18", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 221, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Homewood, Alabama + 163 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00463567" }, { "nct_id": "NCT02518139", "title": "A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "TD-4208", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1060, "start_date": "2015-09", "completion_date": "2017-06", "has_results": true, "last_update_posted_date": "2022-02-24", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 1, "location_summary": "Easley, South Carolina", "locations": [ { "city": "Easley", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02518139" }, { "nct_id": "NCT00388882", "title": "Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium", "type": "DRUG" }, { "name": "ipratropium bromide / albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 327, "start_date": "2006-10-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2023-12-01", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Lakewood, California • Sepulveda, California + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Lakewood", "state": "California" }, { "city": "Sepulveda", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00388882" }, { "nct_id": "NCT01172821", "title": "Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "tiotropium Respimat® low dose", "type": "DRUG" }, { "name": "tiotropium Respimat® high dose", "type": "DRUG" }, { "name": "50 mcg salmeterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1032, "start_date": "2010-08", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-09-02T08:02:01.838Z", "location_count": 18, "location_summary": "Los Angeles, California • Stockton, California • Centennial, Colorado + 15 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" }, { "city": "Panama City", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01172821" } ] }